These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11257031)

  • 1. DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening.
    Sereno D; Roy G; Lemesre JL; Papadopoulou B; Ouellette M
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1168-73. PubMed ID: 11257031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action.
    Sereno D; Cavaleyra M; Zemzoumi K; Maquaire S; Ouaissi A; Lemesre JL
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3097-102. PubMed ID: 9835497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of luciferase expressing Leishmania donovani axenic amastigotes as primary model for in vitro screening of antileishmanial compounds.
    Ravinder ; Bhaskar ; Gangwar S; Goyal N
    Curr Microbiol; 2012 Dec; 65(6):696-700. PubMed ID: 22945482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum.
    Sereno D; Holzmuller P; Lemesre JL
    Acta Trop; 2000 Jan; 74(1):25-31. PubMed ID: 10643904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protein of the leucine-rich repeats (LRRs) superfamily is implicated in antimony resistance in Leishmania infantum amastigotes.
    Genest PA; Haimeur A; Légaré D; Sereno D; Roy G; Messier N; Papadopoulou B; Ouellette M
    Mol Biochem Parasitol; 2008 Mar; 158(1):95-9. PubMed ID: 18164495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of scorpiand-like azamacrocycle derivatives in promastigotes and intracellular amastigotes of Leishmania infantum and Leishmania braziliensis.
    Marín C; Clares MP; Ramírez-Macías I; Blasco S; Olmo F; Soriano C; Verdejo B; Rosales MJ; Gomez-Herrera D; García-España E; Sánchez-Moreno M
    Eur J Med Chem; 2013 Apr; 62():466-77. PubMed ID: 23395967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental studies on the evolution of antimony-resistant phenotype during the in vitro life cycle of Leishmania infantum: implications for the spread of chemoresistance in endemic areas.
    Sereno D; Guilvard E; Maquaire S; Cavaleyra M; Holzmuller P; Ouaissi A; Lemesre JL
    Acta Trop; 2001 Dec; 80(3):195-205. PubMed ID: 11700176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences.
    Vermeersch M; da Luz RI; Toté K; Timmermans JP; Cos P; Maes L
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3855-9. PubMed ID: 19546361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes.
    Ephros M; Waldman E; Zilberstein D
    Antimicrob Agents Chemother; 1997 May; 41(5):1064-8. PubMed ID: 9145870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes.
    Sereno D; Holzmuller P; Mangot I; Cuny G; Ouaissi A; Lemesre JL
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2064-9. PubMed ID: 11408224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes.
    El Fadili K; Messier N; Leprohon P; Roy G; Guimond C; Trudel N; Saravia NG; Papadopoulou B; Légaré D; Ouellette M
    Antimicrob Agents Chemother; 2005 May; 49(5):1988-93. PubMed ID: 15855523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of NanoLuc-PEST expressing Leishmania mexicana as a new drug discovery tool for axenic- and intramacrophage-based assays.
    Berry SL; Hameed H; Thomason A; Maciej-Hulme ML; Saif Abou-Akkada S; Horrocks P; Price HP
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006639. PubMed ID: 30001317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
    Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L
    Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of nicotinamide/antileishmanial drug combinations.
    Gazanion E; Vergnes B; Seveno M; Garcia D; Oury B; Ait-Oudhia K; Ouaissi A; Sereno D
    Parasitol Int; 2011 Jan; 60(1):19-24. PubMed ID: 20884376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An axenic amastigote system for drug screening.
    Callahan HL; Portal AC; Devereaux R; Grogl M
    Antimicrob Agents Chemother; 1997 Apr; 41(4):818-22. PubMed ID: 9087496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-genome comparative RNA expression profiling of axenic and intracellular amastigote forms of Leishmania infantum.
    Rochette A; Raymond F; Corbeil J; Ouellette M; Papadopoulou B
    Mol Biochem Parasitol; 2009 May; 165(1):32-47. PubMed ID: 19393160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
    Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
    Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania infantum: stage-specific activity of pentavalent antimony related with the assay conditions.
    Carrió J; de Colmenares M; Riera C; Gállego M; Arboix M; Portús M
    Exp Parasitol; 2000 Jul; 95(3):209-14. PubMed ID: 10964649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro 'time-to-kill' assay to assess the cidal activity dynamics of current reference drugs against Leishmania donovani and Leishmania infantum.
    Maes L; Beyers J; Mondelaers A; Van den Kerkhof M; Eberhardt E; Caljon G; Hendrickx S
    J Antimicrob Chemother; 2017 Feb; 72(2):428-430. PubMed ID: 27707992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania infantum amastigotes resistant to nitric oxide cytotoxicity: Impact on in vitro parasite developmental cycle and metabolic enzyme activities.
    Holzmuller P; Hide M; Sereno D; Lemesre JL
    Infect Genet Evol; 2006 May; 6(3):187-97. PubMed ID: 15905133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.